The two faces of cervical adenocarcinoma in situ

International Journal of Gynecological Pathology

Volumn 29, Issue 4, 2010, Pages 378-385

  Smedts, Frank ^a   Ramaekers, Frans C S ^b   Hopman, Anton H N ^b  

^a JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 13; CYTOKERATIN 17; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 5; CYTOKERATIN 7; CYTOKERATIN 8; PROTEIN BCL 2; PROTEIN P16; PROTEIN P63; KERATIN; TUMOR MARKER; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UTERINE CERVIX ADENOCARCINOMA IN SITU; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; ADENOCARCINOMA; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; RETROSPECTIVE STUDY; UTERINE CERVIX TUMOR;

ADENOCARCINOMA; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS; UTERINE CERVICAL NEOPLASMS;

EID: 77954129848     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/PGP.0b013e3181cd3175     Document Type: Article

References (35)

1. Woodman CB, Collins SI, Young LS. The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer 2007;7: 11-22.
2. Smedts F, Ramaekers F, Robben H, et al. Changing patterns of keratin expression during progression of cervical intraepithelial neoplasia. Am J Pathol 1990;136:657-68.
3. Smedts F, Ramaekers FC, Vooijs PG. The dynamics of keratin expression in malignant transformation of cervical epithelium: a review. Obstet Gynecol 1993;82:465.
4. Witkiewicz A, Lee KR, Brodsky G, et al. Superficial (early) endocervical adenocarcinoma in situ: a study of 12 cases and comparison to conventional AIS. Am J Surg Pathol 2005;29: 1609-14.
5. Christopherson WM, Nealon N, Gray LA Sr. Noninvasive precursor lesions of adenocarcinoma and mixed adenosquamous carcinoma of the cervix uteri. Cancer 1979;44:975-83.
6. Johnston C. Cervical adenocarcinoma in situ: a persistent clinical dilemma. Lancet 1997;350:1337-8.
7. Park JJ, Sun D, Quade BJ, et al. Stratified mucin-producing intraepithelial lesions of the cervix: adenosquamous or columnar cell neoplasia? Am J Surg Pathol 2000;24:1414-9.
8. Goldstein NS, Ahmad E, Hussain M, et al. Endocervical glandular atypia: does a preneoplastic lesion of adenocarcinoma in situ exist? Am J Clin Pathol 1998;110:200-9.
9. Brown LJ, Wells M. Cervical glandular atypia associated with squamous intraepithelial neoplasia: a premalignant lesion? J Clin Pathol 1986;39:22-8.
10. Colgan TJ, Lickrish GM. The topography and invasive potential of cervical adenocarcinoma in situ, with and without associated squamous dysplasia. Gynecol Oncol 1990;36:246-9.
11. Fu YS, Berek JS, Hilborne LH. Diagnostic problems of in situ and invasive adenocarcinomas of the uterine cervix. Appl Pathol 1987;5:47-56.
12. Cherry CP, Glucksmann A. Incidence, histology, and response to radiation of mixed carcinomas (adenoacanthomas) of the uterine cervix. Cancer 1956;9:971-9.
13. Steiner G, Friedell GH. Adenosquamous carcinoma in situ of the cervix. Cancer 1965;18:807-10.
14. Ince TA, Cviko AP, Quade BJ, et al. p63 Coordinates anogenital modeling and epithelial cell differentiation in the developing female urogenital tract. Am J Pathol 2002;161:1111-7.
15. Hockenbery D, Nunez G, Milliman C, et al. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990;348:334-6.
16. Miettinen M, Sarlomo-Rikala M. Expression of calretinin, thrombomodulin, keratin 5, and mesothelin in lung carcinomas of different types: an immunohistochemical analysis of 596 tumors in comparison with epithelioid mesotheliomas of the pleura. Am J Surg Pathol 2003;27:150-8.
17. Ramaekers F, Huysmans A, Schaart G, et al. Tissue distribution of keratin 7 as monitored by a monoclonal antibody. Exp Cell Res 1987;170:235-49.
18. van Muijen GN, Ruiter DJ, Franke WW, et al. Cell type heterogeneity of cytokeratin expression in complex epithelia and carcinomas as demonstrated by monoclonal antibodies specific for cytokeratins nos. 4 and 13. Exp Cell Res 1986;162:97-113.
19. Troyanovsky SM, Guelstein VI, Tchipysheva TA, et al. Patterns of expression of keratin 17 in human epithelia: dependency on cell position. J Cell Sci 1989;93(Pt 3):419-26.
20. Kwaspen FH, Smedts FM, Broos A, et al. Reproducible and highly sensitive detection of the broad spectrum epithelial marker keratin 19 in routine cancer diagnosis. Histopathology 1997;31:503-16.
21. Reuschenbach M, Waterboer T, Wallin KL, et al. Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-associated cancers. Int J Cancer 2008;123:2626-31.
22. Ter Harmsel B, Smedts F, Kuijpers J, et al. Bcl-2 immuno-reactivity increases with severity of CIN: a study of normal cervical epithelia, CIN, and cervical carcinoma. J Pathol 1996; 179:26-30.
23. Martens JE, Smedts F, van Muyden RC, et al. Reserve cells in human uterine cervical epithelium are derived from mullerian epithelium at midgestational age. Int J Gynecol Pathol 2007;26: 463-8.
24. Wetzels RH, Holland R, van Haelst UJ, et al. Detection of basement membrane components and basal cell keratin 14 in noninvasive and invasive carcinomas of the breast. Am J Pathol 1989;134:571-9.
25. Wetzels RH, Kuijpers HJ, Lane EB, et al. Basal cell-specific and hyperproliferation-related keratins in human breast cancer. Am J Pathol 1991;138:751-63.
26. Fadare O, Wang SA, Hileeto D. The expression of cytokeratin 5/6 in invasive lobular carcinoma of the breast: evidence of a basal-like subset? Hum Pathol 2008;39:331-6.
27. Livasy CA, Perou CM, Karaca G, et al. Identification of a basal-like subtype of breast ductal carcinoma in situ. Hum Pathol 2007;38:197-204.
28. Crum CP. Contemporary theories of cervical carcinogenesis: the virus, the host, and the stem cell. Mod Pathol 2000;13: 243-51.
29. Vooijs GP. Benign proliferative reactions, interepithelial neoplasia and invasive cancer of the urterine cervix. In: Bibbo M, ed. Diagnostic Cytopathology (1st ed.). Philadelphia: W.B. Saunders Co.; 1991:153-230.
30. A tribute to Stanley F. Patten, Jr, MD, PhD. Cancer 1997, 81:315-36.
31. Boon ME, Kirk RS, Rietveld-Scheffers PE. The morphogenesis of adenocarcinoma of the cervix - a complex pathological entity. Histopathology 1981;5:565-77.
32. Smedts F, Ramaekers F, Troyanovsky S, et al. Keratin expression in cervical cancer. Am J Pathol 1992;141:497-511.
33. Witkiewicz AK, Hecht JL, Cviko A, et al. Microglandular hyperplasia: a model for the de novo emergence and evolution of endocervical reserve cells. Hum Pathol 2005;36:154-61.
34. Schurch W, McDowell EM, Trump BF. Long-term organ culture of human uterine endocervix. Cancer Res 1978;38: 3723-33.
35. Hopman AH, Theelen W, Hommelberg PP, et al. Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer. J Pathol 2006;210:412-9.